Literature DB >> 31520998

Burkitt-like lymphoma in a pediatric patient with familial adenomatous polyposis.

Katie M Strobel1, Jacquelyn N Crane2, Kathryn L Bradford2, Yalda Naeini3, William A May4, Vivian Y Chang5.   

Abstract

Familial adenomatous polyposis (FAP) is an autosomal dominant condition that predisposes to multiple malignancies, most commonly colorectal carcinoma, but has rarely been associated with lymphoma. We discuss one patient found to have Burkitt-like Lymphoma (BLL) with 11q aberration in the setting of previously undiagnosed FAP. We review the literature of FAP and associated malignancies and the provisional WHO classification of Burkitt-like lymphoma with 11q aberration. Both FAP and Burkitt-like lymphoma with 11q aberration involve perturbation of the MYC network and this may provide insight into a connection between these two diagnoses. However, further study is needed to elucidate if there is an increased risk of BLL and other subtypes of lymphoma among patients with FAP in order to provide optimal counseling and surveillance for patients with FAP.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  11q aberration; Burkitt-like lymphoma; Familial adenomatous polyposis; MYC network

Mesh:

Year:  2019        PMID: 31520998      PMCID: PMC8123106          DOI: 10.1016/j.cancergen.2019.09.001

Source DB:  PubMed          Journal:  Cancer Genet


  20 in total

1.  Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement.

Authors:  Barbara Pienkowska-Grela; Grzegorz Rymkiewicz; Beata Grygalewicz; Renata Woroniecka; Paulina Krawczyk; Katarzyna Czyz-Domanska; Jan Walewski
Journal:  Med Oncol       Date:  2010-07-27       Impact factor: 3.064

2.  Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern.

Authors:  Julio Finalet Ferreiro; Julie Morscio; Daan Dierickx; Lukas Marcelis; Gregor Verhoef; Peter Vandenberghe; Thomas Tousseyn; Iwona Wlodarska
Journal:  Haematologica       Date:  2015-03-20       Impact factor: 9.941

3.  Association of the APC gene product with beta-catenin.

Authors:  B Rubinfeld; B Souza; I Albert; O Müller; S H Chamberlain; F R Masiarz; S Munemitsu; P Polakis
Journal:  Science       Date:  1993-12-10       Impact factor: 47.728

Review 4.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

5.  Primary cutaneous T-cell-rich B-cell lymphoma and Hodgkin's disease in a patient with Gardner's syndrome.

Authors:  J Kamarashev; R Dummer; M H Schmidt; W Kempf; M O Kurrer; G Burg
Journal:  Dermatology       Date:  2000       Impact factor: 5.366

6.  Familial adenomatous polyposis and duodenal lymphoma: report of a case.

Authors:  F A Frizelle; C T Hemmings; M R Whitehead; A D Spigelman
Journal:  Dis Colon Rectum       Date:  2003-12       Impact factor: 4.585

7.  Intron 4 mutation in APC gene results in splice defect and attenuated FAP phenotype.

Authors:  Deborah W Neklason; Cindy H Solomon; Amy L Dalton; Scott K Kuwada; Randall W Burt
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

Review 8.  Extra-intestinal manifestations of familial adenomatous polyposis.

Authors:  Emma J Groen; Annemieke Roos; Friso L Muntinghe; Roelien H Enting; Jakob de Vries; Jan H Kleibeuker; Max J H Witjes; Thera P Links; André P van Beek
Journal:  Ann Surg Oncol       Date:  2008-07-09       Impact factor: 5.344

9.  Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.

Authors:  H A Poirel; M S Cairo; N A Heerema; J Swansbury; A Aupérin; E Launay; W G Sanger; P Talley; S L Perkins; M Raphaël; K McCarthy; R Sposto; M Gerrard; A Bernheim; C Patte
Journal:  Leukemia       Date:  2008-11-20       Impact factor: 11.528

10.  Diminished WNT -> β-catenin -> c-MYC signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors.

Authors:  Joseph Juan; Teruyuki Muraguchi; Gioia Iezza; Rosalie C Sears; Martin McMahon
Journal:  Genes Dev       Date:  2014-03-03       Impact factor: 11.361

View more
  1 in total

1.  Burkitt-like lymphoma with 11q aberration in a patient with AIDS and a patient without AIDS: Two cases reports and literature review.

Authors:  Jing Wang; Li Ma; Jianghong Guo; Yanfeng Xi; Enwei Xu
Journal:  Open Med (Wars)       Date:  2021-03-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.